12-Jan-2011 - Enlight Biosciences, a Boston, US-based drug discovery and development technologies company, has formed the new company, Entrega, which focuses on oral drug delivery techniques.
11-Jan-2011 - Advances in materials technology are driving the autoinjection drug delivery device market according to new research.
10-Jan-2011 - Drug developers are “aggressively changing” research and development (R&D) methods in the pursuit of the next blockbuster, according to the Tufts Centre for the Study of Drug Development (Tufts CSDD).
23-Dec-2010 - West Pharmaceutical Services plans to move into new 171,000 sq ft headquarters, with office and laboratory space, in Pennsylvania, US by 2013.
16-Dec-2010 - Generex has been awarded a new patent for its buccal drug delivery platform technologies.
15-Dec-2010 - SurModics said it may sell its pharmaceutical unit to focus on its medical device platform, I-vation delivery system and diagnostics businesses.
14-Dec-2010 - Pharma should forget about ‘the next blockbuster drug’ and invest more money creating novel drug delivery systems with emerging developers to enhance product value and efficacy, say researchers.
14-Dec-2010 - Intercell has killed development of its Travellers’ Diarrhoea Vaccine Patch after the product failed in clinical trials which will lead to job cuts and a dramatic reduction of R&D expenses.
09-Dec-2010 - IDRI is developing adjuvant formulations to support sustainable production of pandemic influenza vaccines after being awarded a BARDA contract.
01-Dec-2010 - Cambridge Consultants and Sun Pharma have developed a dry powder inhaler that administers a metered dose of the drug to the deep lung, regardless of the strength of the patient’s intake of breath.
29-Nov-2010 - The primary containers and drug delivery system production company, Gerresheimer AG, is further investing in prefilled syringes with the launch of a new production line.
23-Nov-2010 - Nose-to-brain delivery can become a reality, even for molecules with high molecular weights, but barriers relating to administration and adsorption remain, according to a panel at AAPS.
18-Nov-2010 - Syringe maker Unilife attributed increased first-quarter losses to higher expenditure, costs associated with relocation to the US and the construction of its new global headquarters and production facility in York, Pennsylvania.
17-Nov-2010 - Spencer Pharmaceutical’s board of directors in favour of $0.97 per share buyout offer from anonymous buyer.
17-Nov-2010 - GEA Pharma Systems stamps its authority in the Asian Pacific’s emerging freeze drying industry acquiring Beijing Sino-German Tianhe Technology (BGST).
15-Nov-2010 - Outsourcing-Pharma reviews the latest developments in drug delivery with news from HepaLife Technologies and Jeiven, SurModics and Edge, as well as EDAP, Epitarget AS and INSERM.
15-Nov-2010 - A report by GBI Research predicts the drug delivery market will grow by 10.3 per cent annually in the years leading up to 2016.
10-Nov-2010 - Novartis says it plans to submit its microchip containing ‘smart-pill’ technology to European regulators within 18 months.
08-Nov-2010 - Penwest Pharmaceuticals shareholders have voted in favour of Endo Pharmaceuticals takeover plan, paving the way for the $144m merger.
08-Nov-2010 - Novartis is teaming up with Arab Company for Pharmaceutical Products (Arabio) to provide Saudi Arabia and surrounding regions with vaccines for common diseases.
08-Nov-2010 - Alnylam Pharmaceuticals, Medtronic and CHDI Foundation are collaborating to advance RNAi delivered by an implantable infusion device for treating Huntingdon’s.
03-Nov-2010 - Cambrex buys 51 per cent stake in Indian formulations firm Zenara Pharma, citing efforts to grow in emerging markets as key driver.
02-Nov-2010 - Baxter International will sell its US generic injectables business to UK-based manufacturer Hikma Pharmaceuticals
25-Oct-2010 - Unilife wins US Department of Agriculture (USDA) as guarantor for new manufacturing facility and global headquarters in York, Pennsylvania, US.
21-Oct-2010 - Access Pharmaceuticals and Lotus Pharmaceuticals have both moved to protect their oral delivery technologies with patents.